Blood Substitute Approved in S. Africa

Article

JOHANNESBURG, South Africa-A new blood product that has yet to be approved in the US or Europe has been approved in South Africa.

Hemopure is made from cow hemoglobin and is the first human blood substitute. It can be kept for two years at room temperature and has been created from American cows that are seemingly disease-free. Although the manufacturing company, Biopure, says the product can be used as a substitute, doctors say it better to use Hemopure as a bridge until blood supplies are available for transfusion.

Once used, Hemopure loses its effectiveness in a day or two, requiring more transfusions. It also does not give the body platelets and plasma as donated blood does.

Biotechnology companies have been working for two decades to develop an oxygenating product. At least three other companies are in late stages of development of a similar product.

Biopure plans on filing an application for approval of Hemopure in the US and Europe this year. The company has already received approval for a different blood substitute for dogs.

Information from www.arizonarepublic.com

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content